Fibronectin (FN) is a major extracellular matrix protein involved in various biological events. This study demonstrated that the third FN type III repeat (FnIII3) and several fragments containing the repeat promote cell spreading and migration of human dermal fibroblasts (HDFs), whereas the fourth repeat (FnIII4) did not. A variety of cell types also spread on FnIII3 in a cell-type-specific manner, but not on FnIII4. Immunofluorescence assays revealed that FnIII3 induced the organization of focal contacts and stress fibres in HDFs. Cyclic [RGDFV] peptides with a D-Phe residue, which are selective inhibitors of cell adhesion to vitronectin, inhibited HDF spreading on FnIII3 equally with GRGDS, indicating little involvement of aV-integrins in FnIII3 spreading. An anti-b1 integrin mAb inhibited cell spreading on FnIII3 and FN. To our knowledge, this is the first demonstration that a novel domain of FnIII3 functions in cell spreading and migration through an interaction with unresolved b1 integrin(s) in an RGD-dependent manner.
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Many types of cells can attach, spread, and migrate on plastic coated with extracellular matrix (ECM) proteins such as fibronectin (FN), vitronectin (Vn), laminin (Ln) and collagen in vitro. These interactions occur via a specific cell-surface receptor called integrin (1) . All known integrins consist of one a and one b subunit, each of which can determine ligand specificity (1) . In mammals, 18 a and 8 b subunits have been identified that combine to produce 24 integrins. Six type III FN repeats, including the fifth (III5) (2), III9 (3), III10 (4), EDA (5), III14 (6) and IIICS (7) , are recognized by their respective integrin.
FN plays a key role in many biological processes, including cell adhesion, migration, proliferation and differentiation (8) . Asaga et al. (9) previously showed the involvement of FN in collagen gel contraction and developed a monoclonal antibody (mAb A3A5) that binds to FN and inhibits contraction. Subsequently, we mapped its epitope within FNIII4-5 (10) . In the present study, we aimed to reveal the biological significance of the epitope regions by testing their effects on cell adhesion and migration. FN cDNA fragments containing three consecutive or single FN type III repeats were expressed as 10Â His-tagged proteins, affinity-purified to homogeneity with metal chelating columns, and further examined in vitro for their adhesive properties with a variety of cell types, including human dermal fibroblasts (HDFs). We describe the presence of a novel FN type III3 repeat that promotes cell spreading when used as a substrate. To elucidate the integrin(s) involved in the spreading, we tested the effect of an anti-b1 integrin mAb and several RGD-peptides on cell spreading. In addition, we conducted cell migration assays and found that FNIII3 has the potential to promote HDF migration, similar to FN.
Experimental procedure
Cell culture HDFs were obtained from Kurabo Industries (Osaka, Japan). Human G361 melanoma cells, human HepG2 hepatocarcinoma cells, and murine Swiss 3T3 cells were obtained from the American Type Culture Collection (Rockville, MD, USA). Murine MC3T3-E1 pre-osteoblast cells and B16 melanoma cells were obtained from the Riken Cell Bank (Tsukuba, Japan). Cells were maintained in dishes containing Dulbecco's modified Eagle's medium (DMEM; Gibco, Rockville, MD, USA) or Minimum Essential medium alpha (a-MEM, Wako, Japan), supplemented with 10% (w/v) fetal bovine serum (Hyclone, Logan, UT, USA), 10 mM sodium bicarbonate, 20 mM HEPES [N-(2-hydroxyethyl)piperazine-N 0 -2--ethanesulfonic acid], 100 IU/ml penicillin G, and 100 mg/ml streptomycin sulfate at 37 C and 5% CO 2 .
Recombinant FN fragments
To clone the cDNA fragments of the human FN type III repeats into an expression vector, the corresponding regions were amplified by RTPCR. Briefly, first-stand cDNA was prepared from Trizoltreated HDFs, followed by RT with an oligo dT12-15 primer (Invitrogen, Carlsbad, CA, USA). Target cDNA fragments were amplified with LA Taq DNA polymerase (Takara, Shiga, Japan) and a set of Nde1 site-flanked FN primers (Table 1) . PCR-amplified FN cDNAs were electrophoretically purified in agarose gels, digested with Nde I and then ligated into Nde I-digested pET-16b plasmid vectors encoding an N-terminal 10Â His-tag (Novagen, Madison, WI, USA). Correct insertion and the absence of PCRgenerated errors in the constructs were verified by DNA sequencing.
The resulting constructs were named pET/FNIII2-4, pET/FNIII3-5, pET/FNIII4-6 and pET/FNIII5-7. To clone FNIII3 and FNIII4, we performed an inverse polymerase chain reaction (IPCR) as previously described (11) . Briefly, IPCR for cloning FNIII3 was performed with PrimeSTAR HD DNA polymerase (Takara) using pET/FNIII3-5 as a DNA template and 3r and 5f as oligos ( Table 1 ). The resulting products contained both III3 and III5 in the pET-16b vector and were partially digested with NdeI, circularized by ligation and transfected into Escherichia coli DH5a cells. The transformant containing FNIII3 was identified with a colony-PCR method using the 3r and 3f oligos (Table 1) and was named pET/ FNIII3. pET/FNIII2-4 was used with the 2r and 4f oligos (Table 1) to clone FNIII4 by IPCR. We named this recombinant pET/FNIII4.
Bacterial expression and purification of FN fusion proteins
The cloned DNAs bearing His-tagged FN type III repeats were expressed in BL21(DE3) E. coli cells as instructed by the manufacturer (Novagen). In brief, protein expression was induced by adding 1 mM IPTG, and the expressed protein was purified on a HiTrap chelating column (GE Healthcare, Uppsala, Sweden), extensively dialysed against phosphate-buffered saline (PBS) using an Oscillatory microdialysis system (Daiichi Pure Chemicals, Tokyo, Japan), and recovered for use in cell adhesion assays. Protein concentration was quantified using a Micro BCA protein assay reagent kit (Pierce, Rockford, IL, USA). FN fusion proteins were separated by 12.5% (w/v) SDSPAGE and visualized with dye staining. Standard proteins were purchased from New England Biolabs (NEB, Beverly, MA, USA) or Daiichi Pure Chemicals.
Cell spreading assay
Cell adhesiveness of the purified FN fusion proteins was determined by cell spreading assays as previously described (12 
Cell migration assays
Cell migration assays for the FN fusion proteins were performed by using Oris Universal Cell Migration Assembly kit as instructed by the manufacturer (Platypus Technologies, WI, USA). Briefly, proteins were coated on Oris-compatible 96-well plastic plates at 10 mg/ml, blocked with heat-denatured BSA, washed with PBS and dried. Oris stoppers were inserted into each well before adding the cell. In each well, 5 Â 10 4 HDF cells suspended in DMEM were added and incubated to allow cell attachment for 3 h at 37 C in 5% CO 2 before starting the assay. The stoppers were then removed to allow cell migration to a central detection zone for 12 to 24 h at 37 C in 5% CO 2 in an incubator. Thereafter, cells were fixed with 4% PFA and stained with 0.25% (w/v) toluidine blue (15) . The migrated cells in the plate equipped with a black detection mask were observed with a microscopy at low magnification (40Â) or photographed using transmitted light.
Fibroblast growth arrest
Cell growth of HDFs was arrested by treating with mitomycin-C (MMC) (Sigma). MMC is an antibiotic with anti-proliferative properties. HDFs were suspended in regular culture medium, added to each well in 96-well culture plate (No.3072, Beckton Dickinson) at 5 Â 10 3 cells/well, and allowed to adhere for 3 h at 37 C in 5% CO 2 before treating with the reagents. Cells were treated with different concentration of MMC at 0.62 to 40 mg/ml for 2 h. At the end of treatment, the MMC-untreated cells were fixed with PFA and used later in comparison as a reference. Meanwhile, HDF cells were fed with fresh medium and incubated further for 3 days, washed with PBS, fixed with PFA, stained with toluidine blue and solubilized into 0.5% SDS in PBS. The absorbance at 640 nm (A 640 ) was determined on a Spectrophotometer (Model V-520, JASCO, Tokyo, Japan). The absorbance was found to be a linear function of number of cells. In cell migration assay for growth-arrested cells, we treated HDFs with MMC at 10 mg/ml for 2 h at 37 C in 5% CO 2 , detached to add cells to each well in 96-well plate (No. 3072) that was pre-coated with Fn and Fn fusion proteins. As the control, MMC-untreated cells were included for comparison. We incubated cells for 14 h in the cell migration assay as described above and evaluated the cell migration-promoting activity for each protein with or without MMC.
Immunofluorescence microscopy HDFs were plated onto EZView 24-well culture dishes (glass bottom, Asahi Techno Glass, Tokyo, Japan) and subjected to immunofluorescence analysis for vinculin. The dishes were coated with 5 mg/ml fusion protein or cellular FN (Fibrogenex, Morton Grove, IL, USA), treated with heat-denatured BSA and washed with PBS. HDFs were plated onto the dishes and incubated for 4 h at 37 C in 5% CO 2 . After washing with PBS, the cells were fixed with 4% (w/v) PFA, permeabilized with 0.25% (v/v) Triton X-100, treated with BSA, incubated with anti-vinculin mAb (clone VIN-11-5; Sigma) as the primary antibody, and treated with biotinylated anti-mouse IgG as the secondary antibody, followed by Alexa Fluor 488-conjugated streptavidin (Molecular Probes, Eugene, OR, USA). F-actin was visualized with the binding of Alexa Fluor 
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Results and discussion
The results of our previous study of fibroblastmediated collagen gel contraction in 3D matrices suggested that FNIII4-5 may be involved in the FN matrix assembly of 3D matrices (10) . This possibility was recently demonstrated in 2D cell cultures, by showing the inhibitory effect of the repeats on FN matrix assembly (16) . However, it remains unclear whether the type III repeats have an effect on cell adhesion in various types of cells. To address this question, we used molecular biological techniques to prepare His-tagged FN fusion proteins that spanned the protein from III2 to III7. These fusion proteins were designated as clones FnIII3, FnIII4, FnIII2-4, FnIII3-5, FnIII4-6 and FnIII5-7 (Fig. 1A) , and the size of each was in agreement with the length of the sequence deduced from the original fragment (Fig. 1B) .
We first tested cell spreading activity using clones FnIII2-4, FnIII3-5, FnIII4-6 and FnIII5-7. As a reference, we included Fn-120kDa in the assay (Fig. 1C) . On Fn-120kDa, HDFs spread in a dose-dependent manner, with maximal spreading at the Fn-120kDa concentration of 1.0 mg/ml, as previously shown (13) . Among the four clones tested, clone FnIII3-5 stimulated the highest dose-dependent spreading activity. FnIII2-4 also stimulated dose-dependent spreading, but it was less active than FnIII3-5. In contrast, clones FnIII4-6 and FnIII5-7 displayed substantially reduced activities (595% decrease). These results suggest that the potential for the promotion of cell spreading may be located in the III3 repeat, but not in the III4 repeat.
Subsequently, we separately prepared each repeat. As shown in Fig. 1C , FnIII3 exhibited substantially higher activities, whereas FnIII4 had greatly reduced activity. This finding indicates that FNIII3 has potential activity for promoting cell spreading of HDFs. The amounts of protein needed to promote 50% spreading activity were 1.0 mg/ml (8.3 nM) for Fn-120kDa, 1.7 mg/ml (106 nM) for FnIII3, 2.8 mg/ml (76 nM) for FnIII3-5 and 6.2 mg/ml (162 nM) for FnIII2-4 ( Table 2 ). The molar ratios with respect to FnIII3 were 1.5 for FnIII2-4 and 0.7 for FnIII3-5, indicating that the potential FNIII3 activity was retained similarly between the two clones. It is unclear why the activity with the III3 repeat was lower than that with clone FnIII2-4. We speculate that the tertiary structure of the FNIII3 repeat may be different in clones FnIII2-4 and FnIII3-5 compared with clone FNIII3 after immobilization on plastic. Previously, Erickson showed the elastic properties of the FN type III repeat (17) . If this is also true of our clones, the FNIII3 in FnIII2-4 would have transitioned reversibly into the unfolded state owing to its labile properties, resulting in a conformation unsuitable for promoting cell spreading. Importantly, these data do not rule out the possibility that either FnIII4 or FnIII2 might have suppressed FnIII3-dependent cell spreading when the repeats were aligned directly in this order.
The adhesive activity of FnIII3 was markedly lower than that of Fn-120kDa; specifically, 10-fold weaker on a molar basis. To determine whether FnIII3 is responsible for only a small fraction of the Fn-120kDa activity, we compared the rate of cell spreading on FnIII3 with the rates on well-known cell adhesive proteins such as Vn (Fig. 1D) . At 20 min, cell spreading on FnIII3 was about 10%, which was much less than that on Fn-120kDa, Vn, or Ln. At 40 min, there was 40% cell spreading on FnIII3 and no spreading on FnIII3-5, whereas Fn-120kDa and Vn had promoted nearly complete cell spreading. At 60 min, cell spreading on FnIII3-5 finally became evident. At 80 min, FnIII3 had promoted nearly 80% spreading, although FnIII3-5 had promoted only 40%. FnIII4 had no activity during the assay. Collectively, these results clearly show that there was a time lag for the promotion of cell spreading by FnIII3 and FnIII3-5, suggesting that a different process may govern these spreading events.
Does the finding of a novel adhesion site of FnIII3 explain the actual mechanism of inhibition of collagen gel contraction by mAb A3A5? We still do not know about it precisely. The A3A5-binding site resides on FnIII4-5 (10). Although we never know whether FnIII4-5 promotes cell spreading, but it may not be active because the repeats lacks FnIII3 from the active repeat of FnIII3-5 in cell spreading. However, FnIII4-5 binds to Fn and inhibits the Fn matrix assembly (16) . If Fn matrix formation is critical for collagen gel contraction, FnIII3-5 could be involved in the assembly as shown for FnIII4-5 unless FnIII3 is harmful for the assembly. Therefore, it may be worth to examine whether FnIII3-5 or FnIII3 can bind Fn and inhibit Fn matrix assembly. Alternatively, if we take the indirect model of inhibition by A3A5, this effect might be secondary one, that is, A3A5 may bind to FnIII4-5 so as to inhibit the interaction of FnIII3 to cellular component(s) including integrins by a steric hindrance. Anyhow, further mechanistic study to reveal the molecule(s) interacting with FnIII3 at cell surfaces is needed.
The role of the III3 repeat in the regulation of cytoskeletal organization was evaluated by examining its effect on the distribution of actin microfilaments (Fig. 2) . HDFs were cultured in serum-free medium on glass plates that had been pre-coated with FN, FnIII3-5, FnIII3, or FnIII4. The plates were blocked with BSA, fixed, and stained for F-actin using Alexa Fluor 594-phalloidin (red, Fig. 2A , D, G, J and M).
Focal contacts are known to be sites of integrin engagement with various ECM proteins together with intracellular proteins, including paxillin, vinculin and tailin (18) . Cells cultured on FN, FnIII3-5, and FnIII3 displayed thick microfilament bundles ( Fig. 2A, D and G) , in contrast to the unorganized pattern characteristic of cells on FnIII4 (Fig. 2J) and BSA (Fig. 2M) . The merged images of the cells that spread on FN (C), FnIII3-5 (F), or FnIII3 (I) showed colocalization of vinculin with actin. These findings Integrin receptors participate in a number of biological processes, including cell adhesion, cell migration and FN matrix assembly (8) . In the present study, we evaluated the activity of FN fragments for cell migration using an Oris Universal Migration Assembly Kit (Fig. 3AC) . We tested cell migration activity using FnIII2-4, FnIII3-5, FnIII4-6, FnIII5-7, FnIII3 and III4. As a reference, we included human cellular Fn in the assay (Fig. 3D) . As demonstrated in Fig. 3D , Fn stimulated cell migration more efficiently Cell spreading activity was assayed for each proteins, at concentrations up to 60 mg/ml.
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at University of Wisconsin-Madison General Library System on March 17, 2010 http://jb.oxfordjournals.org compared with a non-specific protein BSA as a control. When migration is examined over time, cell migration on Fn in detection zone became evident within 4 h and was mostly linear over 24 h. Among the six clones tested, clones FnIII2-4, FnIII3-5 and III3 stimulated cell migration and followed the same kinetics of migration as shown for Fn. In contrast, three clones, FnIII4-6, FnIII5-7 and III4, displayed substantially reduced activity (Fig. 3D) . These results suggest that the potential for the promotion of cell migration may be located in the III3 repeat, but not in the III4 repeat. This conclusion coincides with results on cell spreading analysis for all proteins tested (Fig. 1) , suggesting that cell adhesion is the key step for controlling cell migration. Exceptionally, FnIII2-4 was less active than FnIII3-5 at the beginning of cell spreading, but showed similar potential for cell migration each other, implying that initial step of cell to ECM interaction is not always rate-limiting in cell migration, but may be affected differently depending upon the properties of the ECM. The possible intrinsic difference between FnIII2-4 and FnIII3-5 should be clarified in future.
Cell adhesion is a prerequisite for molecular interaction between the cell and the ECM substrate. Cell movement on the substrate involves a number of individual steps, such as adhesion, protrusion, de-adhesion and contraction. During migration on substrate, cells assemble adhesion machinery that is composed of integrins and other intracellular components at focal contact in the leading edge and disassemble it at the trailing edge (19) . Active remodeling of the ECM by proteolysis and secretion may promote such adhesion dynamics. Cell contraction is also needed to move the body of the cell and may promote the process of disassembly (20) . To generate motility forces, complexes that interplay between the actin cytoskeleton and adhesion sites organized with ECM proteins are also needed (19, 20) . In addition, signals for controlling cell migration are transduced to intracellular proteins by matrix-bound integrin receptors (1820). Considering these findings, we propose that integrin(s) are involved in cell migration mediated by FnIII3, as was previously shown for whole FN molecules (21) . ECM is known to involve in many biological events, such as cell adhesion, migration, proliferation and differentiation (1) . To evaluate the role of cell proliferation on cell migration during the assay, we arrested cell proliferation by treating the cell with an anti-proliferative antibiotic, mitomycin-C (MMC). To determine the lowest effective dose for arresting, we treated HDF cells at different concentration of MMC for 2 h, detached, harvested and incubated in normal culture medium for 3 days. At the beginning of the assay, control cells were fixed and used later in comparison. We stained fixed cells with toluidine blue to quantify cell numbers by measuring absorbance at 640 nm. Figure 4A shows the results. We observed a dose-dependent growth inhibition by MMC in the range of 0.6240 mg/ml of MMC. The lowest effective dose of MMC was turned to be 10 mg/ml. At the concentration of 2040 mg/ml, MMC severely damaged the cell. In the absence or presence of MMC at 10 mg/ml, we cultured HDFs for 2 h and used them for cell migration assay. Figure 4B shows the results. The ratio of cell number of MMC-treated to MMC-untreated was 0.91 for Fn; 0.91, FnIII2-4; 0.92, FnIII3-5; 0.89, FnIII4-6; 0.97, FnIII5-7, 0.90, FnIII3, 0.89, FnIII4 and 0.92, BSA, respectively. These results indicate 510% of migrated cells were proliferative and growth suppression has only negligible effect on cell migration. Therefore, we suggest that the results shown in Fig. 3D mostly reflect the difference of potentials for cell migration in each protein tested.
We examined the effect of rat anti-human integrin b1 antibody (mAb13) (14) on cell spreading to identify the integrin receptors involved in FnIII3-mediated cell spreading (Fig. 5A) . In the absence of antibody, HDFs fully spread on all proteins tested. In the presence of mAb13, spreading was severely inhibited on FN, FnIII3-5, FnIII3, and Ln, but not on Vn. This effect was not seen with rat control IgG, indicating the specificity of the antibody in the assay. These results are consistent with the recognition of a mAb13 shared by FN and Ln (14) . Thus, cell spreading on FnIII3-5 and FnIII3 may be mediated by an integrin consisting of b1 and one or more unresolved a subunits.
To obtain more information on the unresolved a subunit(s), we examined the cellular specificity of spreading on FnIII3 using the human cell lines, such as HDF, G361 and HepG2, and the murine MC3T3-E1, Swiss 3T3 and B16 cell lines. The adhesiveness of each cell line was tested with FN, FnIII3 and FnIII4 as 2D substrates (Fig. 5B) . FnIII4 showed no adhesion with any of the cell lines tested. The HepG2 and B16 cells did not spread on FN or FnIII3. G361 and Swiss 3T3 cells showed intermediate activity on FnIII3, but negligible activity on FN, suggesting the presence of cryptic activity in FnIII3. HDFs and MC3T3-E1 cells showed the highest spreading activity on FN and FnIII3. These results suggest the involvement of a unique type of b1 integrin in cell spreading on FnIII3.
To our knowledge, FN interacts with a4b1, a5b1, a8b1, aVb1, aIIbb3, aVb3, aVb6, a4b7 and a9b7 integrins (1, 5) . Flow cytometry studies have revealed that HDFs express a3b1, a4b1, a5b1, aVb1, aVb3 and aVb5 integrins (22) . The cell adhesion function of these six integrins is differentially affected by RGD peptides; the first two integrins, a3b1 and a4b1, are classified as non-RGD integrins and are insensitive to the RGD-peptide, whereas the other four are RGDintegrins and sensitive to the peptide (1) . A previous study with immobilized integrins showed that the inhibitory activity of the cyclic RGD-peptide , which contains a D-amino acid residue (underlined), was about 10-fold that of GRGDS for aVb3 and was equal to that of GRGDS for a5b1 (23). Aumailley et al. (24) reported that cyclo[RGDFV] was more effective than GRGDS for inhibiting cell spreading mediated by Vn in melanoma A375, mammary epithelia HBL and fibrosarcoma HT1080 cells. Three aV integrins (aVb1, aVb3 and aVb5) participate in the recognition of Vn (1) .
To learn more about the involvement of these integrins in cell spreading on FnIII3, we examined the effects of GRGDS and cyclo[RGDFV] on the spreading of HDFs. The peptide GRGES was also included as an inactive control peptide (Fig. 6) . The inhibition profiles for GRGDS and cyclo [RGDFV] were clearly similar to each other, suggesting that the involvement of aVb1, probably aVb3 and aVb5 in FnIII3-dependent cell spreading of HDFs could be excluded. As shown in Fig. 5A , spreading of HDFs on FnIII3 is likely to be mediated by b1 integrins. Taken together, this information leads us to speculate that one of two b1 integrins (a4b1, or a5b1) may be a candidate integrin for FnIII3 in HDFs. However, the involvement of a4b1 is unlikely for the following two reasons. First, a4b1 and a9b1 recognize the LDV sequence and related sequences (57), but FnIII3 does not contain any of those sequences. Second, although B16 cells preferentially spread on substrates containing the LDV sequence (6, 7), we observed no B16 cell spreading on FnIII3 (Fig. 5B) . Therefore, we speculate that a5b1 interacts with FnIII3 in HDFs. Taking into account the complexity of ligand recognition for a5b1, it is possible that it may bind FnIII3. The FN interaction with a5b1 is not restricted to the RGD sequence in FNIII10, as this integrin binds to repeats III9 and III10 as well as to type I(1-9) and type II(1-2) repeats (25) . Furthermore, a5b1 recognizes another site http://jb.oxfordjournals.org in addition to RGD that synergizes with RGD for high-affinity FN recognition (3, 12) . Our RT-PCR analysis revealed that HepG2 cells express negligible levels of a5 mRNA (data not shown), and HepG2 cells were never observed to spread on FN or FNIII3 (Fig. 5B) . Alternatively, if we assume that a5b1 integrin is a functionally dominant receptor needed for spreading on Fn in G361 and Swiss 3T3 cells, those cells might have to spread also on the FN. However, we found that G361 and Swiss 3T3 cells spread on FNIII3, but not intact FN (Fig. 5B) . Therefore, this result suggests that receptors other than a5b1 integrin could be involved in the cell spreading on FNIII3. It is also conceivable that secondary receptor(s), such as those described for a3Ab1 (26) , may be involved in cell adhesion to FnIII3. More importantly, our studies do not rule out the involvement of other integrins in the interaction with FnIII3.
In summary, we demonstrated for the first time that FnIII3 promotes cell spreading of both HDFs and mouse pre-osteoblast cells and mediates cryptic cell spreading of human melanoma cells and mouse Swiss 3T3 cells. We also revealed the inhibitory effect of an anti-human integrin b1 antibody and RGD peptides on FnIII3-mediated cell spreading of HDFs. The results also provide evidence that FnIII3 promotes cell migration, presumably via RGD-dependent integrins. Consequently, this study raises the interesting possibility that FnIII3 may contain a novel sequence(s) recognized by b1 integrin(s) combined with a specific, but unresolved, RGD-dependent a-subunit(s). Further studies on FnIII3-mediated cell spreading should allow the determination of key sequences important for cell adhesion as well as the identification of their binding receptor integrins. 
